Indivior Pharmaceuticals, Inc. (INDV) Free cash flow 2022–2025
Indivior Pharmaceuticals, Inc. (INDV) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$93.0MFY2025 · since FY2022: -$9.0M → -$93.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$93.0M | -1428.6% |
| FY2024 | $7.0M | +102.3% |
| FY2023 | -$308.0M | -3322.2% |
| FY2022 | -$9.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice